Hepabene® (Hepabene®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspcapsules
Composition:

1 capsule contains:

active substances: herbs extract medicinal herb extract dry 275.10 mg (corresponding to 4.13 mg of the sum of fumaric alkaloids inrecalculated on protopin), milk thistle fruit extract dry 83.10 mg (corresponding to 50 mg of silymarin, including at least 22 mg of silibin);

Excipients: cellulose microcrystalline 80.10 mg, corn starch 20.10 mg. talc 8.40 mg, macrogol-6000 4.50 mg, copovidone 4.50 mg, magnesium stearate 2.10 mg. silicon dioxide colloidal 2.10 mg.

Sheath: gelatin 79.94 mg. dye iron oxide yellow 0.67 mg, iron oxide dye red 0.15 mg. ferric oxide black oxide 0.04 mg. titanium dioxide 1.29 mg. purified water 13.92 mg.

Description:Hard gelatin capsules № 0 with opaque lid and body of light brown color. The contents of the capsules are powder from light brown to dark brown in a non-uniform color with white or yellowish or gray patches. Conglomerates or seals are allowed.
Pharmacotherapeutic group:Cholagogue of plant origin
ATX: & nbsp
  • Other drugs for the treatment of bile duct diseases
    • Pregnancy and lactation:It is not recommended to use the drug during pregnancy and during breastfeeding.
    Dosing and Administration:

    Inside with food, not liquid, squeezed a little water.

    Adults usually take 1 capsule 3 times a day for two weeks.

    At night pain syndrome it is recommended to take an additional 1 capsule before bedtime.

    If necessary, the daily dose of the drug can be increased to 6 capsules (maximum daily dose) in 3-4 divided doses during the day.

    Side effects:

    Allergic reactions are possible. Sometimes, there may be a laxative effect and an increase in diuresis.

    If there is no therapeutic effect or if there are side effects not described in this manual, you should stop taking the medication and inform the treating doctor about it.

    Effect on the ability to drive transp. cf. and fur:The use of the drug does not affect the ability to perform potentially hazardous activities requiring increased concentration of attention and speed of psychomotor reactions (control of vehicles, work with moving mechanisms, dispatcher, operator).
    Form release / dosage:Capsules.
    Packaging:For 10 capsules in PVDC / aluminum blister. For 3 or 10 blisters together with instructions for use in a cardboard box.
    Storage conditions:

    At a temperature of no higher than 25 ° C, in a dry place.

    Keep out of the reach of children!

    Shelf life:

    3 years.

    Do not use after the expiration date!

    Terms of leave from pharmacies:On prescription
    Registration number:П N012369 / 01
    Date of registration:17.10.2007 / 15.12.2016
    Expiration Date:Unlimited
    The owner of the registration certificate:Teva Pharmaceutical Enterprises Co., Ltd.Teva Pharmaceutical Enterprises Co., Ltd. Israel
    Manufacturer: & nbsp
    Representation: & nbspTeva Teva Israel
    Information update date: & nbsp24.03.2017
    Illustrated instructions
      Instructions
      Up